Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00075439Phase 2Completed
Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
GastrinomaGlucagonomaInsulinoma+6 more
Principalinvestigator
NCT00131911Phase 2Completed
Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
GastrinomaGlucagonomaInsulinoma+7 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Syma Iqbal, MD

University of Southern California

Related
5 trials

Shared therapeutic areas:

GastrinomaGlucagonomaInsulinoma+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score24%

Francois Benard, MD

BC Cancer

Related
7 trials

Shared therapeutic areas:

Neuroendocrine TumorsGastrinomaInsulinoma+1 more
Similarity Score12%

Stephen Michael Hahn

Abramson Cancer Center at Penn Medicine

Related
6 trials

Shared therapeutic areas:

Metastatic Gastrointestinal Carcinoid TumorRecurrent Gastrointestinal Carcinoid Tumor

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

George Albert Fisher M.D. Ph.D.

Stanford University

Related
6 trials

Shared therapeutic areas:

Neuroendocrine Tumors
Similarity Score3%

Bassel El-Rayes, MD

Emory University Winship Cancer Institute

Related
4 trials

Shared therapeutic areas:

Neuroendocrine Tumors
Similarity Score3%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Neuroendocrine Tumors

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Martin Gotthardt, Prof. Dr.

Radboud University Medical Center

Related
4 trials

Shared therapeutic areas:

Insulinoma
Similarity Score3%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Insulinoma
Similarity Score3%

Neeta Pandit-Taskar, MD

Memorial Sloan Kettering Cancer Center

Related
8 trials

Shared therapeutic areas:

Neuroendocrine Tumors
Similarity Score3%

Brennan Spiegel, MD, MSHS

Cedars-Sinai Medical Center

Related
10 trials

Shared therapeutic areas:

Neuroendocrine Tumors

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00075439Phase 2PrincipalInvestigator

Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

GastrinomaGlucagonomaInsulinoma+6 more
Completed
NCT00131911Phase 2PrincipalInvestigator

Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

GastrinomaGlucagonomaInsulinoma+7 more
Completed

All 2 trials loaded